<SEC-DOCUMENT>0001140361-25-004241-index.html : 20250213
<SEC-HEADER>0001140361-25-004241.hdr.sgml : 20250213
<ACCEPTANCE-DATETIME>20250213142023
ACCESSION NUMBER:		0001140361-25-004241
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250213
DATE AS OF CHANGE:		20250213

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adaptive Biotechnologies Corp
		CENTRAL INDEX KEY:			0001478320
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				270907024
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91363
		FILM NUMBER:		25619345

	BUSINESS ADDRESS:	
		STREET 1:		1165 EASTLAKE AVE E
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98109
		BUSINESS PHONE:		206-659-0067

	MAIL ADDRESS:	
		STREET 1:		1165 EASTLAKE AVE E
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98109

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adaptive TCR Corp
		DATE OF NAME CHANGE:	20091209

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nikko Asset Management Americas, Inc.
		CENTRAL INDEX KEY:			0001480751
		ORGANIZATION NAME:           	
		IRS NUMBER:				941302123
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0310

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		605 THIRD AVENUE
		STREET 2:		38TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10158
		BUSINESS PHONE:		212-610-6100

	MAIL ADDRESS:	
		STREET 1:		605 THIRD AVENUE
		STREET 2:		38TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10158
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ef20043541_ex99-1.htm
<DESCRIPTION>EXHIBIT A
<TEXT>
Document 2 - file: ef20043541_ex99-1.htm

</DOCUMENT>
</SEC-DOCUMENT>